Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

Business Wire November 9, 2022

PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2022

Business Wire November 3, 2022

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022

Business Wire November 2, 2022

PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference

Business Wire August 30, 2022

PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Business Wire August 16, 2022

Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results

Business Wire August 15, 2022

Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio

Business Wire August 11, 2022

Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics' EsoGuard® and EsoCheck® Technologies

Business Wire August 4, 2022

PAVmed to Hold a Business Update Conference Call on August 16, 2022

Business Wire August 3, 2022

PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy's 2022 Most Influential Black Executives in Corporate America

Business Wire July 19, 2022

Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference

Business Wire July 18, 2022

PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO

Business Wire May 13, 2022

PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results

Business Wire May 12, 2022

Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results

Business Wire May 11, 2022

Lucid Diagnostics' Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans

Business Wire May 9, 2022

Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study

PR Newswire May 4, 2022

PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit

GlobeNewswire April 28, 2022

PAVmed to Hold a Business Update Conference Call on May 12, 2022

Business Wire April 26, 2022

Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022

Business Wire April 25, 2022

Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination

Business Wire April 4, 2022